With 1 in 7 Australian women diagnosed with breast cancer, the demand for a minimally invasive, accurate diagnostic test is growing. Whilst health professionals recommend bi-annual breast screening for women aged 50-74, the invasive nature of imaging and ultrasound techniques leads to low compliance. There is well documented evidence that early cancer detection markedly improves
Read More
At a time when women are more aware of potential health issues than ever, Volpara Health (ASX: VHT) is set to drastically improve how breast cancer is talked about with imaging technology driven by artificial intelligence that will help prevent advanced stage breast cancer. The imagery will be provided to women in collaboration with Sheila
Read More